Literature DB >> 29459767

Mcl-1 and Bcl-xL sequestration of Bak confers differential resistance to BH3-only proteins.

Colin Hockings1,2,3, Amber E Alsop1,2, Stephanie C Fennell1,2, Erinna F Lee4,5,6, W Douglas Fairlie4,5,6, Grant Dewson1,2, Ruth M Kluck7,8.   

Abstract

The prosurvival Bcl-2 family proteins Mcl-1 and Bcl-xL inhibit apoptosis by sequestering BH3-only proteins such as Bid and Bim (MODE 1) or the effector proteins Bak and Bax (MODE 2). To better understand the contributions of MODE 1 and MODE 2 in blocking cell death, and thus how to bypass resistance to cell death, we examined prescribed mixtures of Bcl-2 family proteins. In a Bim and Bak mixture, Bcl-xL and Mcl-1 each sequestered not only Bim but also Bak as it became activated by Bim. In contrast, in a Bid and Bak mixture, Bcl-xL preferentially sequestered Bid while Mcl-1 preferentially sequestered Bak. Notably, Bcl-xL could sequester Bak in response to the BH3 mimetic ABT-737, despite this molecule targeting Bcl-xL. These findings highlight the importance of Bak sequestration in resistance to anti-cancer treatments, including BH3 mimetics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29459767      PMCID: PMC5864222          DOI: 10.1038/s41418-017-0010-6

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  59 in total

1.  Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.

Authors:  Marina Konopleva; Rooha Contractor; Twee Tsao; Ismael Samudio; Peter P Ruvolo; Shinichi Kitada; Xingming Deng; Dayong Zhai; Yue-Xi Shi; Thomas Sneed; Monique Verhaegen; Maria Soengas; Vivian R Ruvolo; Teresa McQueen; Wendy D Schober; Julie C Watt; Tilahun Jiffar; Xiaoyang Ling; Frank C Marini; David Harris; Martin Dietrich; Zeev Estrov; James McCubrey; W Stratford May; John C Reed; Michael Andreeff
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

2.  Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.

Authors:  Anthony Letai; Michael C Bassik; Loren D Walensky; Mia D Sorcinelli; Solly Weiler; Stanley J Korsmeyer
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

Review 3.  BCL-2 family antagonists for cancer therapy.

Authors:  Guillaume Lessene; Peter E Czabotar; Peter M Colman
Journal:  Nat Rev Drug Discov       Date:  2008-12       Impact factor: 84.694

4.  Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis.

Authors:  Grant Dewson; Ruth M Kluck
Journal:  J Cell Sci       Date:  2009-08-15       Impact factor: 5.285

5.  Dissociation of Bak α1 helix from the core and latch domains is required for apoptosis.

Authors:  Amber E Alsop; Stephanie C Fennell; Ray C Bartolo; Iris K L Tan; Grant Dewson; Ruth M Kluck
Journal:  Nat Commun       Date:  2015-04-16       Impact factor: 14.919

6.  Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance.

Authors:  Jessie Pécot; Laurent Maillet; Janic Le Pen; Céline Vuillier; Sophie de Carné Trécesson; Aurélie Fétiveau; Kristopher A Sarosiek; Florian J Bock; Frédérique Braun; Anthony Letai; Stephen W G Tait; Fabien Gautier; Philippe P Juin
Journal:  Cell Rep       Date:  2016-12-20       Impact factor: 9.423

Review 7.  Apoptosis and oncogenesis: give and take in the BCL-2 family.

Authors:  Fabien Llambi; Douglas R Green
Journal:  Curr Opin Genet Dev       Date:  2011-01-13       Impact factor: 5.578

8.  BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response.

Authors:  Kristopher A Sarosiek; Xiaoke Chi; John A Bachman; Joshua J Sims; Joan Montero; Luv Patel; Annabelle Flanagan; David W Andrews; Peter Sorger; Anthony Letai
Journal:  Mol Cell       Date:  2013-09-26       Impact factor: 17.970

9.  Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

Authors:  N Rampino; H Yamamoto; Y Ionov; Y Li; H Sawai; J C Reed; M Perucho
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

10.  Bcl-XL inhibits membrane permeabilization by competing with Bax.

Authors:  Lieven P Billen; Candis L Kokoski; Jonathan F Lovell; Brian Leber; David W Andrews
Journal:  PLoS Biol       Date:  2008-06-10       Impact factor: 8.029

View more
  13 in total

1.  Avoiding adsorption of Bcl-2 proteins to plasticware is important for accurate quantitation.

Authors:  Colin Hockings; Sweta Iyer; Rachel T Uren; Ruth M Kluck
Journal:  Cell Death Differ       Date:  2019-02-13       Impact factor: 15.828

2.  Mcl-1 and Bok transmembrane domains: Unexpected players in the modulation of apoptosis.

Authors:  Estefanía Lucendo; Mónica Sancho; Fabio Lolicato; Matti Javanainen; Waldemar Kulig; Diego Leiva; Gerard Duart; Vicente Andreu-Fernández; Ismael Mingarro; Mar Orzáez
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-22       Impact factor: 11.205

3.  In Vivo ERK1/2 Reporter Predictively Models Response and Resistance to Combined BRAF and MEK Inhibitors in Melanoma.

Authors:  Ileine M Sanchez; Timothy J Purwin; Inna Chervoneva; Dan A Erkes; Mai Q Nguyen; Michael A Davies; Katherine L Nathanson; Kristel Kemper; Daniel S Peeper; Andrew E Aplin
Journal:  Mol Cancer Ther       Date:  2019-07-03       Impact factor: 6.261

4.  Decoding the concealed transcriptional signature of the apoptosis-related BCL2 antagonist/killer 1 (BAK1) gene in human malignancies.

Authors:  Konstantina Athanasopoulou; Panagiotis G Adamopoulos; Glykeria N Daneva; Andreas Scorilas
Journal:  Apoptosis       Date:  2022-07-25       Impact factor: 5.561

5.  Mitochondrial E3 ubiquitin ligase MARCHF5 controls BAK apoptotic activity independently of BH3-only proteins.

Authors:  Mark F van Delft; Grant Dewson; Allan Shuai Huang; Hui San Chin; Boris Reljic; Tirta M Djajawi; Iris K L Tan; Jia-Nan Gong; David A Stroud; David C S Huang
Journal:  Cell Death Differ       Date:  2022-09-28       Impact factor: 12.067

6.  Resveratrol attenuates cerebral ischaemia reperfusion injury via modulating mitochondrial dynamics homeostasis and activating AMPK-Mfn1 pathway.

Authors:  Jinbao Gao; Haijiang Wang; Yunjun Li; Wende Li
Journal:  Int J Exp Pathol       Date:  2019-12-22       Impact factor: 1.925

7.  BFL1 modulates apoptosis at the membrane level through a bifunctional and multimodal mechanism showing key differences with BCLXL.

Authors:  Hector Flores-Romero; Olatz Landeta; Begoña Ugarte-Uribe; Katia Cosentino; Miguel García-Porras; Ana J García-Sáez; Gorka Basañez
Journal:  Cell Death Differ       Date:  2018-12-18       Impact factor: 15.828

Review 8.  Cardioprotective Role of Melatonin in Acute Myocardial Infarction.

Authors:  Zhenhong Fu; Yang Jiao; Jihang Wang; Ying Zhang; Mingzhi Shen; Russel J Reiter; Qing Xi; Yundai Chen
Journal:  Front Physiol       Date:  2020-04-29       Impact factor: 4.566

9.  Irisin activates Opa1-induced mitophagy to protect cardiomyocytes against apoptosis following myocardial infarction.

Authors:  Ting Xin; Chengzhi Lu
Journal:  Aging (Albany NY)       Date:  2020-03-10       Impact factor: 5.682

10.  Bax inhibitor 1 preserves mitochondrial homeostasis in acute kidney injury through promoting mitochondrial retention of PHB2.

Authors:  Jin Wang; Pingjun Zhu; Ruibing Li; Jun Ren; Yingmei Zhang; Hao Zhou
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.